NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer treatment aims to avoid surgery
Disease control Not yet recruitingThis study is testing two different drug combinations, delivered directly into the bladder, to treat a specific type of bladder cancer. The goal is to see if these treatments can effectively control the cancer without needing surgery. The trial will enroll about 20 adults with in…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New bladder wash could spare patients from major surgery
Disease control Not yet recruitingThis study is testing whether washing the bladder with two chemotherapy drugs, gemcitabine and docetaxel, can control high-risk bladder cancer that has stopped responding to the standard BCG treatment. The goal is to see if this approach can effectively treat the cancer and preve…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC